Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Codexis (CDXS) over the last 17 years, with Q3 2025 value amounting to $25.4 million.

  • Codexis' Cash & Equivalents fell 3231.07% to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year decrease of 3231.07%. This contributed to the annual value of $19.3 million for FY2024, which is 7041.59% down from last year.
  • As of Q3 2025, Codexis' Cash & Equivalents stood at $25.4 million, which was down 3231.07% from $26.8 million recorded in Q2 2025.
  • In the past 5 years, Codexis' Cash & Equivalents ranged from a high of $139.7 million in Q1 2021 and a low of $18.3 million during Q1 2025
  • In the last 5 years, Codexis' Cash & Equivalents had a median value of $90.1 million in 2022 and averaged $76.4 million.
  • Per our database at Business Quant, Codexis' Cash & Equivalents surged by 7119.33% in 2021 and then tumbled by 7980.85% in 2024.
  • Codexis' Cash & Equivalents (Quarter) stood at $116.8 million in 2021, then decreased by 2.41% to $114.0 million in 2022, then plummeted by 42.87% to $65.1 million in 2023, then plummeted by 70.42% to $19.3 million in 2024, then skyrocketed by 31.6% to $25.4 million in 2025.
  • Its Cash & Equivalents was $25.4 million in Q3 2025, compared to $26.8 million in Q2 2025 and $18.3 million in Q1 2025.